We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$2.93B
AUM Growth
+$1.14B
Cap. Flow
+$1.03B
Cap. Flow %
35.37%
Top 10 Hldgs %
55.12%
Holding
624
New
176
Increased
136
Reduced
111
Closed
159

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$172M
2
MU icon
Micron Technology
MU
+$158M
3
AMD icon
Advanced Micro Devices
AMD
+$121M
4
C icon
Citigroup
C
+$119M
5
TSLA icon
Tesla
TSLA
+$105M

Sector Composition

Rank Sector Weight
1 Technology 42.28%
2 Financials 13.02%
3 Consumer Discretionary 12.26%
4 Energy 4.52%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHI icon
226
D.R. Horton
DHI
$42.3B
$1.18M 0.04%
8,370
+1,438
+21% +$211K
SCHL icon
227
Scholastic
SCHL
$792M
$1.17M 0.04%
32,889
+8,903
+37% +$318K
DECK icon
228
Deckers Outdoor
DECK
$13.3B
$1.17M 0.04%
7,224
+3,696
+105% +$569K
COF icon
229
Capital One
COF
$134B
$1.15M 0.04%
8,323
-580
-7% -$81.4K
HLX icon
230
Helix Energy Solutions
HLX
$1.41B
$1.13M 0.04%
94,860
+65,720
+226% +$733K
MAS icon
231
Masco
MAS
$15.3B
$1.13M 0.04%
16,981
+12,679
+295% +$894K
CI icon
232
Cigna
CI
$74.6B
$1.12M 0.04%
+3,394
New +$1.17M
LH icon
233
Labcorp
LH
$25.9B
$1.12M 0.04%
5,501
+1,072
+24% +$218K
PDM
234
Piedmont Realty Trust
PDM
$1.19B
$1.11M 0.04%
152,624
-90,185
-37% -$627K
ROST icon
235
Ross Stores
ROST
$81.9B
$1.1M 0.04%
7,589
-948
-11% -$131K
AL
236
DELISTED
Air Lease Corp
AL
$1.09M 0.04%
22,920
+7,870
+52% +$382K
ALLO icon
237
Allogene Therapeutics
ALLO
$694M
$1.09M 0.04%
466,110
+34,924
+8% +$103K
POWL icon
238
Powell Industries
POWL
$7.71B
$1.07M 0.04%
22,455
+17,991
+403% +$938K
GLPI icon
239
Gaming and Leisure Properties
GLPI
$12.8B
$1.07M 0.04%
23,713
-569
-2% -$25.1K
CNX icon
240
CNX Resources
CNX
$5.2B
$1.07M 0.04%
43,854
+13,914
+46% +$340K
REVG
241
DELISTED
REV Group
REVG
$1.06M 0.04%
42,715
-2,594
-6% -$63.7K
CIM
242
Chimera Investment
CIM
$1B
$1.05M 0.04%
81,857
+11,900
+17% +$151K
BIO icon
243
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.03M 0.04%
+3,785
New +$1.1M
CSCO icon
244
Cisco
CSCO
$479B
$1.03M 0.04%
21,657
-3,837
-15% -$182K
R icon
245
Ryder
R
$10.1B
$995K 0.03%
8,035
-284
-3% -$34.3K
AN icon
246
AutoNation
AN
$6.92B
$993K 0.03%
6,230
-308
-5% -$50.3K
FHN icon
247
First Horizon
FHN
$12.1B
$973K 0.03%
+61,726
New +$935K
LDOS icon
248
Leidos
LDOS
$17.3B
$963K 0.03%
+6,599
New +$922K
UPBD icon
249
Upbound Group
UPBD
$1.16B
$956K 0.03%
+31,137
New +$995K
STT icon
250
State Street
STT
$50.7B
$955K 0.03%
+12,902
New +$962K

Similar funds

Caxton Associates (New York)'s Q2 2024 Portfolio in Review

As of Q2 2024, Caxton Associates (New York) held 624 positions worth $2.93B, up 64% from $1.78B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Caxton Associates (New York) deployed $1.03B of net new capital in Q2 2024, opening 176 new positions and adding to 136 existing holdings. Its largest new stake was Intel: 5,250,000 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $49.3M trimmed.

  • Caxton Associates (New York)'s largest Q2 2024 buy was Intel: 5,250,000 shares worth $163M.
  • Caxton Associates (New York) added most to Micron Technology in Q2 2024, an estimated $158M increase.
  • Caxton Associates (New York)'s biggest Q2 2024 reduction was Broadcom, cutting an estimated $49.3M.
  • Caxton Associates (New York) fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $50.3M.
  • Caxton Associates (New York)'s ten largest holdings make up 55% of its $2.93B portfolio in Q2 2024.
  • Caxton Associates (New York) opened 176 new positions and closed 159 in Q2 2024.
  • Caxton Associates (New York)'s portfolio value rose 64% quarter-over-quarter to $2.93B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.